Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

PHA News Archive - October 11, 2002

PHAnews
vol 3, Number 21
October 11, 2002

PHAnews is a bi-weekly internet information resource for patients and caregivers. If you have suggested items for upcoming issues please send a brief description and web link to PHAnews editor, Sally Maddox skmaddox@bellsouth.net Welcome to this resource from PHA!

SPOTLIGHT ON PHA WEB

There's a new item you might want to check on www.phassociation.org . A new "Books and Guides" section. With links to reading material containg pertinent info on PH and related topics. Go to:

www.phassociation.org/learn/Books_and_Guides.htm

A list of topics for this issue are:

1) WHO Functional Assessment for Pulmonary Hypertension (modified after NYHA functional classification)6
2) PH Awareness Month
3) Canadian Health Authority Approves Remodulin(R) To Treat Pulmonary Arterial Hypertension
4) Experts debunk vaccine myths, urge people to get shots early this year

WHO Functional Assessment for Pulmonary Hypertension (modified after NYHA functional classification)6

The World Health Organization (WHO) class system is used in determining whether you are eligible for certain drugs. For example, to go on Tracleer you must a Class 3 or worse to be considered for this treatment.

www.clevelandclinicmeded.com/medical_info/pharmacy/MarApr2002/table2.h tm PH Awareness Month

This year the Pulmonary Hypertension Association has set aside the month of November for the purpose of creating awareness about pulmonary hypertension, locally, nationally and internationally.

www.phassociation.org/awareness/awareness_month.asp

Canadian Health Authority Approves Remodulin(R) To Treat Pulmonary Arterial Hypertension

PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR - News) announced today that the Canadian Therapeutics Products Directorate (TPD) has approved Remodulin(R) (treprostinil sodium) Injection for the long- term, subcutaneous treatment of pulmonary arterial hypertension in NYHA Class III and IV patients who did not respond adequately to conventional therapy.

http://biz.yahoo.com/prnews/021007/nym076_1.html

Experts debunk vaccine myths, urge people to get shots early this year

Oct. 3 — Flu-shot season has begun, and this year marks the first time parents are being urged to get babies and toddlers vaccinated. Health officials expect a record 94 million doses of the vaccine to be available this season and are urging Americans to take advantage of the ample supply.

http://www.msnbc.com/news/816799.asp


Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email pha@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2009 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Adobe Flash Player
free download from Adobe.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH